BackgroundCheck.run
Search For

Dennis B Fuge, 73497 Cafferty Rd, Erwinna, PA 18920

Dennis Fuge Phones & Addresses

497 Cafferty Rd, Erwinna, PA 18920    610-2949789   

4 Kingsbrook Ct, Mendham, NJ 07945    973-9278222   

Randolph, NJ   

Morris Plains, NJ   

Buck, PA   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Mentions for Dennis B Fuge

Dennis Fuge resumes & CV records

Resumes

Dennis Fuge Photo 21

Wood Artist And Teacher

Location:
Mendham, NJ
Industry:
Pharmaceuticals
Work:
Fuges Wild Woods
Wood Artist and Teacher
America Accciation of Woodturners 1988 - 2016
Wood Turner
Meda 1988 - 2016
Vice President Supply Chain and Manufacturing Usa
Medpointe Pharmaceuticals 1988 - 2016
Vice President Manufacturing and Supply Chain
Warner Lambert 1975 - 2001
Marketing Manager
Warner Lambert 2000 - 2001
Director Tct New Product Planning
Education:
University of Cape Town Jan 1, 1980 - 1981
Master of Business Administration, Masters, Business, Business Admin
Rhodes University Jan 1, 1969 - 1974
Rhodes University Jan 1, 1970 - 1974
Pretoria Boys High School
Skills:
Pharmaceutical Industry, Product Development, Supply Chain, Cross Functional Team Leadership, Manufacturing, Fda, Product Launch, Gmp, Biotechnology, Pharmaceutical Sales, Medical Devices, Pharmaceutics, Sop, Validation, Sales Operations, Clinical Development, Sales Effectiveness, Quality Assurance, Technology Transfer, Healthcare, Quality System, Clinical Trials, Oncology, Dermatology, R&D, Lifesciences, Gxp, Drug Development, Capa, Commercialization, Regulatory Submissions, Rheumatology, Wood Turning
Interests:
Wood Turning
Dennis Fuge Photo 22

Dennis Fuges Fuge

Publications & IP owners

Us Patents

Compositions Comprising Azelastine And Methods Of Use Thereof

US Patent:
2010015, Jun 17, 2010
Filed:
Sep 29, 2009
Appl. No.:
12/569548
Inventors:
Dennis Fuge - Somerset NJ, US
John Higson - Plymouth Meeting PA, US
Bryan A. Roecklein - Somerset NJ, US
Gul Balwani - West Windsor NJ, US
Alexander D. D'Addio - Piscataway NJ, US
International Classification:
A61K 31/56
A61K 31/55
A61K 31/549
A61J 1/05
A61J 1/18
US Classification:
514179, 51421705, 5142225, 424464, 604403, 604404
Abstract:
The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also generally relates to pharmaceutical compositions comprising one or more active pharmaceutical ingredients, such as azelastine or pharmaceutically acceptable salts or esters thereof including azelastine hydrochloride, particularly wherein the compositions are provided in unit dosage form. In certain embodiments, the invention provides such unit dosage pharmaceutical compositions comprising azelastine hydrochloride formulated for use as nasal sprays and/or ocular solutions or drops. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g., for the symptomatic relief of a variety of allergic and non-allergic conditions, particularly conjunctivitis, sinusitis, rhinitis and rhinosinusitis. The compositions and methods of the present invention provide significant value in terms of patient acceptability, convenience, and compliance.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.